&apos;Act on oncology&apos; as a new comprehensive approach to assess prostate cancer centres : Method description and results of a pilot study by W. Voigt et al.
‘Act on Oncology’ as a New Comprehensive Approach to
Assess Prostate Cancer Centres – Method Description
and Results of a Pilot Study
Wieland Voigt1*, Josef Hoellthaler1, Tiziana Magnani2, Vito Corrao2, Riccardo Valdagni2
1 Siemens AG, Healthcare Sector, Customer Solutions Division, H CX CRM-VA HCC ONC, Erlangen, Germany, 2 Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Abstract
Background: Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer centres. It requires the
optimisation of medical and operational processes and the integration of the different medical and non-medical
stakeholders.
Objective: To develop a standardised operational process assessment tool basing on the capability maturity model
integration (CMMI) able to implement multidisciplinary care and improve process quality and efficiency.
Design, Setting, and Participants: Information for model development was derived from medical experts, clinical
guidelines, best practice elements of renowned cancer centres, and scientific literature. Data were organised in a
hierarchically structured model, consisting of 5 categories, 30 key process areas, 172 requirements, and more than 1500
criteria. Compliance with requirements was assessed through structured on-site surveys covering all relevant clinical and
management processes. Comparison with best practice standards allowed to recommend improvements. ‘Act On
Oncology’(AoO) was applied in a pilot study on a prostate cancer unit in Europe.
Results and Limitations: Several best practice elements such as multidisciplinary clinics or advanced organisational
measures for patient scheduling were observed. Substantial opportunities were found in other areas such as centre
management and infrastructure. As first improvements the evaluated centre administration described and formalised the
organisation of the prostate cancer unit with defined personnel assignments and clinical activities and a formal agreement
is being worked on to have structured access to First-Aid Posts.
Conclusions: In the pilot study, the AoO approach was feasible to identify opportunities for process improvements.
Measures were derived that might increase the operational process quality and efficiency.
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Introduction
Owing to the growing options for diagnosis and treatment, the
optimal management of prostate cancer patients is still controver-
sial. Treatment options include different kinds of surgery and
radiation therapies as well as hormonal therapy, chemotherapy,
and immunotherapy. These options are supplemented by obser-
vational approaches such as active surveillance and watchful
waiting [1,2]. Since some therapies seem to be equally effective,
patients need to be informed objectively about the risks and
benefits of each option [3,4,5].
A multidisciplinary approach facilitates the shared decision-
making between patients and specialists. Multidisciplinary disease
management is further associated with improved outcome in
breast cancer, prostate cancer as well as other types of cancer
[6,7,8,9,10,11,12]. Additionally, it seems to positively impact on
both cost-effectiveness of care and patient satisfaction [10,13].
Multidisciplinary management, however, requires well-integrated
medical and management services and an effective coordination of
clinics, diagnostic routines, treatments, follow-ups, and appoint-
ments with medical and non-medical experts [14,15]. These
patient care processes have to comply with operational processes,
appropriate human, technical, and financial resources, and
optimal infrastructural, administrative, and management support
[10,15].
Earlier quality assessments indicated that the quality of cancer
care varies among prostate cancer centres [16]. Quality assessment
and improvement initiatives as well as certification programs have
therefore been developed to enforce medical standards, adherence
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to guidelines, and to strengthen the multidisciplinary approach
[15,17]. These programs mainly focus on clinical and outcome
related parameters. However, quality and efficiency of operational
processes and centre infrastructure as well as the functional
integration of services are taken less into account. In addition,
maintenance and improvement of care quality by, for example,
certification programs add to operational costs, resulting in a
steadily increasing economic pressure [17]. Given that organisa-
tional improvements and streamlined clinical processes were
shown to reduce costs while retaining quality, process modelling
might be an effective tool to counteract economic constraints
[17,18,19].
In a continuous improvement concept for complex medical
organizations, the assessment of both quality and efficiency of
medical and non-medical processes as well as the definition of
relevant performance indicators are required [20,21,22]. Recog-
nizing this need, we adapted the ‘capability maturity model
integration’ (CMMI) approach to assess complex medical organi-
zations like cancer centers [23]. Basically, CMMI aims at
improving the quality and efficiency of processes as well as the
integration of organisational components and establishes maturity
levels for each individual process [24]. These levels can be used to
benchmark processes and organisations.
Recently, the CMMI approach has been successfully applied by
our group to improve processes in radiology departments [25].
Here we describe the application of the CMMI to more complex
medical organisations such as prostate cancer centres. Model
development comprised the collection of information on all
relevant aspects of cancer centres and structuring these into
categories, key process areas, requirements, and criteria. Accord-
ing to the CMMI principle, a hierarchically structured systematic
assessment matrix was created that enables on-site surveys at
cancer centres. Comparison with current best practice standards
then provides the basis to recommend applicable solutions. A pilot
study at a prostate cancer centre in Italy identified several
measures for process improvement and, importantly, proved the
general applicability of our approach.
Materials and Methods
Project members
The Act On Oncology approach for the systematic assessment
of prostate cancer centres was developed by four consistent team
members with a medical or consulting background (core team).
For specific issues, the core team was supplemented by associate
members with medical (2), consulting (2), biomedical (1), or
technical background (2).
Act On Oncology database
To develop the model, scientific literature, certification criteria
of the German cancer society [26], and medical guidelines were
analysed and consolidated [1,27]. The model was enriched by best
practice elements, which were derived from workshops with
international experts and from best practice experiences of both
renowned cancer centres worldwide and patient organisations
(Germany, USA). Best practice experience also came from the
professional background of team members in internal medicine,
radiation therapy, palliative care, intensive care, and medical
oncology as well as from the knowledge gathered during more
than 500 hospital consulting projects worldwide. Each piece of
information was discussed and prioritised in regular core team
meetings.
Development of the organisational structure
As an established tool for continuous process optimisation in the
industry, the CMMI method provided the basis for the Act On
Oncology approach. It defines five maturity levels of processes:
Level 1 (initial; situational treatment) is defined by rather
unmanaged and arbitrary operational procedures; level 2 (repeat-
able) is characterised by the use of guidelines, leading to controlled
processes; level 3 (defined) uses well-characterised operational
procedures and defined standard processes; level 4 (managed)
applies quantitative key performance indicators for the manage-
ment of processes, making process outcomes more predictable;
level 5 (optimised) involves the continuous improvement of
processes by the use of key performance indicators [24,28].
To adjust the CMMI methodology [24,28] organisational
categories were defined and assorted to different process levels,
based on their relevance for process characterisation and
development. For each category, key process areas were defined
and partitioned into requirements for prostate cancer centres.
These requirements were specified by criteria, which, in turn, were
substantiated by best practice elements extracted from the sources
mentioned above (Figure 1). To continuously improve our
approach, the developmental progress was subjected to periodic
reviews by team members. Mindjet Mindmanager Software was
applied to manage the resulting hierarchically structured knowl-
edge database.
Structured survey and systematic assessment
A structured survey matrix was derived from the comprehensive
database by using the Mindjet Mindmanager Software. This
survey matrix is thought to be used in on-site interviews with
variable numbers of stakeholders depending on the size and
organisation of a centre. Interviewees might comprise physicians,
executive management, medical and non-medical personnel,
administrational staff, and referrers. Obtained information is then
entered into an EXCEL spreadsheet database to allow a
standardised and systematic evaluation of each requirement,
based on the fulfilment of each criterion. Next, fulfilment is
assessed by the team with best practice standards as reference (as
defined by the criteria and notes) and subsequently ranked on a 4-
point Likert-scale ranging from 1 (not fulfilled) to 4 (completely
fulfilled). If information cannot be evaluated, fulfilment is rated as
‘0’. Data are summarised in radial bar charts, along with a
description of problems and potential solutions. In general, Act On
Oncology comprises three phases (systematic assessment, elabora-
tion of results, presentation of findings). The on-site assessment by
three consultants usually lasts for 3 to 4 days. The elaboration and
presentation of results requires 2 to 3 weeks.
Pilot study and validation phase
In December 2012, a pilot study was conducted in a specialised
prostate cancer unit at Fondazione IRCCS Istituto Nazionale dei
Tumori (INT) in Milan, Italy. The INT was selected because of its
long-term experiences in both multidisciplinary care of prostate
cancer patients and prostate cancer research [13,15]. The
multidisciplinary clinic at INT has two components, weekly
multidisciplinary consultations of specialists and weekly clinical
case discussions.
During the on-site survey, 24 employees representing all
relevant clinical processes including management, controlling,
data management, and clinical trial handling were interviewed by
two members of the core team and one associate member,
accompanied by a translator if necessary (Tab. 1). The duration of
each interview was about one hour; the whole interview phase
lasted three days. Additional information on infrastructure and
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IT-related subjects was acquired during a guided tour through the
facility. Obtained information was analysed as described above
and presented in a standardised presentation that included results
and recommendations.
Results
Act On Oncology Model
The following five categories were identified as the superordi-
nate topic areas that characterise the organisational structure of
prostate cancer centres: ‘clinical processes’, ‘centre communica-
tion’, ‘centre management’, ‘infrastructure and IT’, and ‘strategy
and research’. Corresponding to the CMMI approach, categories
were assorted to maturity levels (situational treatment = 1; clinical
process = 2; centre communication and management = 3;
infrastructure and IT = 4; strategy and research = 5). The five
categories were then split into 30 clusters of related activities (key
process areas), which were thought to best characterise the main
functional units. In detail, 16 key process areas were defined for
clinical processes, 8 for centre communication and management, 4
for infrastructure and IT, 2 for strategy and research. The
selection of process areas was continuously challenged and revised
if necessary. Next, these 30 key process areas were divided into 172
requirements. To finally characterise each requirement, 1500
criteria were defined and further substantiated by notes (Figure 1).
Having defined and organised the different categories, process
areas, requirements, and criteria, a structured survey matrix for
on-site interviews was created. After the interview phase, obtained
information was entered into a spreadsheet database and the
degree of fulfilment of each requirement was appraised and
Figure 1. Illustration of the hierarchically structured Act On Oncology model. Five categories derived from the Act On Oncology database
were assorted to different maturity levels according to CMMI (left). The figure exemplifies the ramification of the key process area ‘outpatient
department’ into requirements and criteria, which are further substantiated by notes. With more than 1500 criteria, the model describes best practice
elements in all different fields of a prostate cancer centre.
doi:10.1371/journal.pone.0106743.g001
Table 1. Listing of interview partner.
Affiliation of Interview partner Function of Interview partner
Program Management Director of Prostate Cancer Program, Coordinator of patient scheduling, Project Manager, Controlling, Patient Secretary, Data
manager, IT-specialist
Radiation therapy 2x Radiation Oncologist (dedicated to Brachytherapy), 2x Radiation Oncologist (dedicated to External Radiotherapy), Coordinator
Radiotherapy, Medical Physicist, Nurse
Urology Urologist
Medical Oncology 2x Medical Oncologist
Radiology Director of Radiology, Radiologist
Clinical trials Research nurse, Trial physician
Supportive Therapy Psycho Oncologist, Palliative Care/Pain specialist, Supportive care specialist
doi:10.1371/journal.pone.0106743.t001
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quantified by the team. Results were then visualised in radial bar
charts, thus immediately giving an overview of the process quality
of the whole centre. A three-colour code illustrated the urgency of
management attention (Figure 2).
Pilot study
During the on-site assessment of the INT, several processes and
features were considered best practice when compared with the best
practice experience integrated in the Act On Oncology database.
These processes and features included the weekly multidisciplinary
clinics, the weekly multidisciplinary case discussions, the psycho-
logical support for patients early in the decision making process, and
the existence of active surveillance protocols. In the multidisciplin-
ary clinics, prostate cancer patients are counselled by a multidis-
ciplinary team consisting of urologists, radiation oncologists,
medical oncologists (for advanced, hormone-refractory and meta-
static disease), and psycho-oncologists. Supportive care, rehabilita-
tion, and specialist palliative care interventions are available on
demand. Case discussions then aim at sharing decisions made in the
multidisciplinary clinic, tailoring therapeutic strategies, and evalu-
ating the adherence to guidelines. Urologists, radiation oncologists,
medical oncologists, psychologists regularly participate in these
discussions, while pathologists, radiologists, and experts in support-
ive and palliative care join in on demand. Trained administrative
personnel is further employed to improve the clinical workflow by
reminding patients of their clinic appointments and collecting
required information.
Together with the preparation and adoption of shared
institutional guidelines, these measures were considered to increase
the quality of care and to contribute to a successful enrolment in
protocols, above all in active surveillance studies. Regular patient
satisfaction surveys, the high level of evidence based decision
making, and the considerable contribution to clinical research
were viewed as additional quality indicators.
In contrast, substantial need for improvements was identified in
centre management and infrastructure. For example, the collab-
oration between the departments of urology and radiation
oncology was not defined at the management and strategy level,
and the corporate identity within the prostate cancer unit was not
particularly evident. Most importantly, the prostate cancer
program received limited support from the hospital administra-
tion. In particular, there was no sufficient budget and staffing
allocated to the program, resulting in a continuous need for other
non-institutional funding sources.
Moreover, the INT infrastructure did not support the clinical
workflow optimally. Several bottlenecks such as insufficient
elevator capacity, confusing patient walkways, the absence of an
emergency room, and the lack of formal agreements to rule
specialists’ collaborations were identified. In addition, the facility
did not fulfil the requirements of a patient-friendly building (in
particular, elderly/disabled patients). Problems identified within
Figure 2. Example of an automatically generated radial bar chart providing an overview of the level of fulfilment of each key
process area. Beginning at the centre point, the level of fulfilment of key process areas is indicated along the radius in steps of 10%. Green colour
indicates fulfilment of up to 100% (red # 50%, yellow # 75%). On the outer circle, the corresponding maturity level of each category is provided.
doi:10.1371/journal.pone.0106743.g002
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the key process area ‘patient transportation, material transporta-
tion, and organisation of transportation’ along with their potential
solutions are exemplary illustrated in Figure 3.
In summary, beside several best practice elements, some
opportunities for improvements of operational processes, manage-
ment, and infrastructure were identified. Concrete measures were
suggested in a systematic management summary. A reassessment is
planned in about two years to evaluate whether the suggested
measures lead to the expected improvements.
Discussion
Multidisciplinary care has been recognised to improve the
quality of care and to positively influence outcome in some types of
cancer such as breast cancer [6,12,29]. Therefore, multidisciplin-
ary management of patients with other cancers like prostate cancer
is increasingly advocated [10,13,14,30]. Multidisciplinary man-
agement in specialised prostate cancer centres implies new
organisational and management challenges [10,13,14]. Hospitals
traditionally have a vertical management structure with individ-
ually operated clinics or departments, while a horizontal
management approach would be more appropriate to align and
integrate the different medical, supportive, and management
functions to achieve high medical and operational standards
[21,22,31].
To improve the standard of cancer care, different national and
European certification programs for breast and prostate cancer
care have been launched representing a promising step towards
continuous quality improvement and standardisation of cancer
care [15,17,29,32,33]. However, quality and efficiency of opera-
tional processes and the level of integration of services are usually
not in the main focus of certification programs. Thus, to
complement existing certification programs, we developed the
Act On Oncology approach which isas to our knowledge the first
example to apply the CMMI for the structured assessment of
prostate cancer centers. In contrast to other consulting practices in
the market, the predefined interview matrix of Act On Oncology
allows a quick and reproducible analysis of a center within a few
days.
Act On Oncology aims to generate a holistic view on the
operational processes in each unit of a cancer centre, their
interfaces to each other, and the level of integration. Therefore,
the categories ‘centre management’ and ‘communication’ were
specifically addressed. As suggested by recent publications, the
transition of a purely vertical organised centre into a cross-linked
structure depends on different management functions and an
effective communication among departments and divisions
[21,22,31]. Communication strategies are useful to generate a
corporate identity within a centre but also in the outbound
communication with patients and referrer. Cross-departmental
collaboration is not only a prerequisite to create a corporate
strategy, but is also required for the conduct of clinical trials, which
are an important source for scientific impact and financial
resources. We therefore identified ‘strategy and research’ as
another superordinate category of our model.
Healthcare IT and centre infrastructure were identified as
further overarching categories since both influence the perfor-
mance of healthcare delivery [34]. In health care industry, IT is an
asset that helps to improve quality of health services, to manage
Figure 3. Exemplary result of the pilot study. The graph (bottom left) shows a 50% fulfilment of requirements related to organisation of
transportation, patient transport, and material transport, along with a description of problems and potential solutions (SOP: standard operating
procedure; KPI: key performance indicator).
doi:10.1371/journal.pone.0106743.g003
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rising costs and changing organisational needs, and to improve
data exchange within a centre.
As first of its kind, Act On Oncology establishes reference points
to which process quality and efficiency as well as the level of
integration of the different stakeholders can be related. Improving
the quality of care relies on several factors, from the adoption and
routine application of guidelines for diagnosis, treatment and
follow-up, to the multidisciplinary management of patients
[14,35,36]. In addition, quality of care also bases on structural
issues such as the provision and integration of different services
and resources [13,15,21]. Measures to meet these requirements
may include the centralisation and standardisation of multidisci-
plinary care, the application of IT solutions, the improvement of
management structures, the streamlining of workflow processes
including interfaces with referrers, and the development of joint
strategies [10,13,14,21,22,34,37].
In our pilot study, Act On Oncology identified areas for
improvement on multiple levels. Despite the promising achieve-
ments in the implementation of multidisciplinarity at the staff level,
the pilot study revealed the need for an overriding management
framework to promote the collaboration among departments, to
allow a corporate identity to evolve, and to canvas additional
support. In this regard, it is important to note that an advanced
organisational infrastructure appears to improve both outcomes of
cancer patients [16,38] and cost efficiency of clinical processes
[17,18,19,39]. As a first improvement that has been implemented
in the meanwhile, the centre administration and the Health
Director at INT described and formalised the organisation of the
prostate cancer unit. The document defines both categories of
personnel assigned to the prostate cancer unit (core team, non-
core team, project team) and clinical activities (multidisciplinary
clinics, observational setting clinics, clinical case discussions). The
implementation of this suggested measure can be considered as the
first positive effect of the Act On Oncology assessment. During the
assessment, several features of the prostate cancer unit were
ranked as best practice, reflecting the efforts that have already
been made at the INT: the multidisciplinarity of designated weekly
clinics and tumour board meetings, the presence of a psychologist
in the multidisciplinary clinics and case discussion meetings,
and the existence of an active surveillance program
[10,11,13,14,15,40,41].
Act On Oncology employs a structured and predefined
interview and assessment matrix. The experiences from the
development phase and the pilot study, along with experiences
from the assessment of radiology departments [25], suggest a high
level of reproducibility with low interobserver variability. Howev-
er, one limitation of our method is related to the global diversity of
health care systems. Although several cancer centres in Germany,
Italy, and the US have been analysed, this diversity might not be
appropriately addressed by our model. This is particularly
important once our model should be used for global benchmark-
ing of cancer centres. To address this limitation, our approach is
subjected to a continuous improvement process. We expect that,
after additional global assessments, Act On Oncology might be
applied as a benchmarking tool in the future [22].
Conclusion
In conclusion, Act On Oncology provides a feasible tool to
evaluate quality and efficiency of operational processes in prostate
cancer centres. During a pilot study, several best practices and
opportunities could be identified. Measures for improvement were
elaborated and their effectiveness has to be proven in a future
reassessment. Broad scale assessments will be necessary to apply
Act On Oncology as a benchmarking tool for cancer centres.
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